Senate Counsel, Research
and Fiscal Analysis
Minnesota Senate Bldg.
95 University Avenue W. Suite 3300
St. Paul, MN 55155
(651) 296-4791
Tom Bottern
Director
   Senate   
State of Minnesota
 
 
 
 
 
S.F. No. 2578 - Modifying the Schedules of Controlled Substances
 
Author: Senator Paul T. Anderson
 
Prepared By: Chris Turner, Senate Fiscal Analyst (651/296-4350)
 
Date: March 2, 2018



 

Section 1 adds substances to Schedule I, which makes those substances illegal to sell or possess.  The substances are:

  • Mitragynine and 7-hydroxymitragynine – the main active ingredients in a plant called kratom.  These substances are considered opiates because they activate the same receptors in the brain that opiates, such as morphine and heroin, activate.
  • 4-(4-bromophenyl)-4-dimethylamino-1-phenethylcyclohexanol (bromadol), which is a synthetic opiate that law enforcement agencies have seized during arrests.  It is at least 500 times more potent than morphine, making the treatment of overdoses very difficult.
  • 1-(3-chlorophenyl) piperazine (meta-chlorophenylpiperazine or mCPP), which is a synthetic stimulant that law enforcement agencies have also been seizing.

Section 2 aligns Schedule IV with the version of Schedule IV found in the board’s rule by adding the following opiate drugs:

  • Pentazocine.
  • butorphanol (including its optical isomers).

The additions to Schedule IV are simply to align Schedule IV in the rules and statutes.  Since these drugs are already scheduled in rule, there will be no impact other than clearing up confusion caused by the different versions of the Schedules.  

 
Check on the status of this bill
 
Back to Senate Counsel and Research Bill Summaries page
 

 
This page is maintained by the Office of Senate Counsel, Research, and Fiscal Analysis for the Minnesota Senate.
 
Last review or update: 03/02/2018
 
If you see any errors on this page, please e-mail us at webmaster@senate.mn